Vitamin B12 and Folate
Vitamin B12 is a water-soluble vitamin that is stored in the liver. All vitamin B12 comes from ingestion of foods of animal origin (non-animal sources exist, however, they are not considered reliable sources of the vitamin). It is used in metabolism, in the formation of red blood cells, and in the maintenance of the central nervous system. Vitamin B12 is a necessary cofactor for three important biochemical processes: conversion of methylmalonyl-CoA to succinyl-CoA, and methylation of homocysteine to methionine, and demethylation of methyltetrahydrofolate to tetrahydrofolate (THF). Deficiency of folate coenzymes derived from THF is probably the crucial lesion caused by B12 deficiency.
Vitamin B12 in serum is protein bound, 70% to transcobalamin I (TC I) and 30% to transcobalamin II (TC II). The B12 bound to TC II is physiologically active; that bound to TC I is not. The previously used Schilling test is being utilized less frequently in the assessment of pernicious anemia. New testing algorithms have been developed using B12, methylmalonic acid (MMA), intrinsic factor blocking antibodies, parietal cell autoantibodies, and serum gastrin analysis. However, further study is needed to validate this new strategy. The commonly available competitive protein binding assay measures total B12. It is insensitive to significant decreases in physiologically significant B12 bound to TC II. Low B12 levels warrant treatment; intermediate levels should be followed by the serum methylmalonic acid test (see Methylmalonic Acid entry). Neuropsychiatric disorders caused by low serum B12 level can occur in the absence of anemia or macrocytosis.
Folic acid, also known as Folate, is a type of B vitamin that is used by the body for the production and maintenance of new cells and cellular material such as DNA and RNA. About 20% of folate absorbed is from dietary sources, such as raw fruits and vegetables, liver, and fortified grain products, or from supplemental vitamins. The remainder is derived from intestinal bacteria that synthesize folate.
Dietary deficiency can result from diets devoid of foods rich in folic acid, as may be the case with chronic alcoholics, drug addicts, the elderly, or persons of low socioeconomic status, etc. In addition to low dietary intake, intestinal malabsorption is the second major cause of folate deficiency in humans. Folate levels do not always correlate with the presence or absence of disease. For example, a person with signs and symptoms of folate deficiency may have a normal folate level and conversely, a person with a low folate level may show no evidence of disease. Levels less than 4 ng/mL are suggestive of deficiency; this value was based on National Health and Nutrition Survey III data by consensus. Serum folate is the preferred test rather than RBC folate due to significant lack of reproducibility of the RBC folate test. Both tests will give the same clinical information.
Folic acid deficiency may result in several disorders and conditions such as anemia. Megaloblastic anemia, a type of anemia that is characterized by large red cells, is associated with a decrease in folate levels. Low serum folate levels during pregnancy have also been associated with neural tube defects in the fetus.
A low RBC folate level may indicate either folate or vitamin B12 deficiency. Since a deficiency of either vitamin B12 or folate can cause megaloblastic anemia, it is advisable to determine the concentration of both vitamin B12 and folate in order to properly diagnose the etiology of anemia. Obtaining methylmalonic acid (MMA) and homocysteine levels can aid in distinguishing between folate and vitamin B12 deficiency. In folate deficiency, homocysteine levels are elevated and MMA is normal, whereas in B12 deficiency both homocysteine and MMA are elevated.
- Diagnosis of megaloblastic and macrocytic anemia
- Diagnosis of vitamin B12 deficiency
- Diagnosis of folate deficiency
- Monitor treatment of B12 deficiency
- Monitor therapy with folate
- Evaluation of alcoholic patients
- As an aid in diagnosis of homocysteinemia
Increased in:
- Folate and B12 therapy
- Administration of transfusions
- B12 deficiency due to pernicious anemia can result in normal or elevated serum folate level
- Leukemia (acute myelocytic, chronic myelocytic, chronic lymphocytic, monocytic)
- Marked leukocytosis
- Polycythemia Vera.
(Increased B12 levels are not diagnostically useful).
Decreased in:
- Inadequate intake
- Impaired absorption
- Increased requirements (example: pregnancy, etc.)
- Defective folate metabolism
- Pernicious anemia
- Gastrectomy
- Gastric carcinoma
- Malabsorption (sprue, celiac disease, steatorrhea, regional enteritis, fistulas, bowel resection, fish tapeworm infestation, small bowel bacterial overgrowth)
- Pregnancy
- Dietary deficiency
- HIV infection (with or without malabsorption)
- Chronic high-flux hemodialysis
- Some drugs (e.g., omeprazole, metformin, carbamazepine)
- Pathologic hyperproliferative states (example: sickle cell anemia, hereditary spherocytosis, thalassemia or chronic autoimmune hemolytic anemias)
- Chemotherapeutic agents such as methotrexate, phenytoin and aminopterin
| Analyte | Reference Range |
| Vitamin B12 | 140–820 pg/mL (100–600 pmol/L) |
| Folate Status | ng/mL | nmol/L |
| Normal | 4.2-19.9 | 9.5 – 45.2 |
| Indeterminate | 2.1-4.1 | 4.8 – 9.3 |
| Deficient | Less than 2.1 | <4.8 |
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (SST).
Stability
- Ambient: 2-3 hours (Protect from light)
- Refrigeration: 2-7 days (Protect from light)
- Frozen: 1 month (Protect from light)
- Am J Clin Nutr. 2005;82:1346. [PMID: 16332669]
- Am J Med. 2001 Feb 1;110(2):88-90. [PMID: 11165548]
- Blood Rev. 2006;20:299. [PMID: 16716475]
- Clin Lab Med. 2002;22:435. [PMID: 12134470]
- Arch Intern Med. 1999 Jun 28;159(12):1289-98. [PMID: 10386505]
- Am Fam Physician. 2003 Mar 1;67(5):979-86. [PMID: 12643357]
- Haematologica. 2006;91:1506. [PMID: 17043022]
- Bishop ML, Duben-Engelkirk JL, and Fody EP. Clinical Chemistry Principles, Procedures, Correlations. Philadelphia. Lippincott, 1996.
- McClatchey KD. Clinical Laboratory Medicine, 2nd. Philadelphia. Lippincott Williams & Wilkins, 2002.